Age Gene/Environment Susceptibility Reykjavik Study (AGES)

Icelandic Heart Association

Status: Completed

Conditions: Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT03269656

IHA

ZIAEY000401 (U.S. NIH Grant/Contract)

NO1-AG-1-2100 (Other Grant/Funding Number)

Details and patient eligibility

About

5764 men and women in Iceland, aged 66 to 96 years entered the Ages Gene/Environment Susceptibility (AGES) - Reykjavik Study. Serum 25(OH)D was measured in 5,519 of all 5,764 (96%) participants at study entry in year 2002 through 2006. The main emphasis was on exploring whether pre-diagnostic serum levels of 25(OH)D were associated with survival after cancer diagnosis.

Enrollment: 5,764 patients

Sex: All

Ages: 66 to 98 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• To participate in the AGES-Reykjavik study

Exclusion criteria

• To be diagnosed with cancer before study entry

Trial design

5,764 participants in 1 patient group

AGES-Reykjavik participants

Description:

Exploring whether pre-diagnostic serum levels of 25(OH)D among older individuals living in Iceland were associated with survival after cancer diagnosis. We also assessed the risk of being diagnosed with cancer in association with 25(OH)D levels.